Abstract ES6-3: Breast cancer genetic testing: moving from cancer risk assessment to therapeutic biomarker - KIVIRID

Abstract ES6-3: Breast cancer genetic testing: moving from cancer risk assessment to therapeutic biomarker

Authors: J Balmaña

Published: 2020-03-26

DOI: 10.1158/1538-7445.sabcs19-es6-3

Source: Full article

Abstract

Abstract